Randomized double-blind placebo-controlled phase 2 study of bemarituzumab combined with modified FOLFOX6 (mFOLFOX6) in first-line (1L) treatment of advanced gastric/gastroesophageal junction adenocarcinoma (FIGHT).


Wainberg Z. A., Enzinger P. C., Kang Y., Yamaguchi K., Qin Shukui Q. S., Lee K., ...Daha Fazla

JOURNAL OF CLINICAL ONCOLOGY, cilt.39, sa.3, 2021 (SCI-Expanded, Scopus) identifier

  • Yayın Türü: Makale / Özet
  • Cilt numarası: 39 Sayı: 3
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1200/jco.2021.39.3_suppl.160
  • Dergi Adı: JOURNAL OF CLINICAL ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, EMBASE, Gender Studies Database, International Pharmaceutical Abstracts, MEDLINE, Veterinary Science Database
  • Bezmiâlem Vakıf Üniversitesi Adresli: Evet